6533b7d9fe1ef96bd126ceeb

RESEARCH PRODUCT

A Spatially Resolved Dark- Versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B-Cell Lymphomas

Alessandro MangognaMaurilio PonzoniSabina SangalettiFabio FacchettiClaudio TripodoFederica ZanardiArianna Di NapoliAnand D. JeyasekharanStefano CasolaSaveria MazzaraGaia MorelloM.c. VeglianteClaudia ChiodoniMario P. ColomboAlison VanshoiackFabio IannelliStefano Pileri

subject

0301 basic medicineStromal cellCancer Cancer Systems Biology02 engineering and technologycancer systems biologyBiologyTranscriptome03 medical and health sciencestranscriptomicsImmune systemmedicinecancerTranscriptomicslcsh:ScienceGeneLymph nodeB cellCancerMultidisciplinaryMesenchymal stem cellGerminal centerGene signature021001 nanoscience & nanotechnologyMolecular biologycancer; cancer systems biology; transcriptomics030104 developmental biologymedicine.anatomical_structurelcsh:Q0210 nano-technologySignature (topology)Cancer Systems Biology

description

Summary: We applied digital spatial profiling for 87 immune and stromal genes to lymph node germinal center (GC) dark- and light-zone (DZ/LZ) regions of interest to obtain a differential signature of these two distinct microenvironments. The spatially resolved 53-genes signature, comprising key genes of the DZ mutational machinery and LZ immune and mesenchymal milieu, was applied to the transcriptomes of 543 GC-related diffuse large B cell lymphomas and double-hit (DH) lymphomas. According to the DZ/LZ signature, the GC-related lymphomas were sub-classified into two clusters. The subgroups differed in the distribution of DH cases and survival, with most DH displaying a distinct DZ-like profile. The clustering analysis was also performed using a 25-genes signature composed of genes positively enriched in the non-B, stromal sub-compartments, for the first time achieving DZ/LZ discrimination based on stromal/immune features. The report offers new insight into the GC microenvironment, hinting at a DZ microenvironment of origin in DH lymphomas.

https://doi.org/10.2139/ssrn.3614131